Latest filing published 16 May 2014 for HEAT BIOLOGICS, INC., €3,665.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +43.0%Entry US$55,546.27 · Close at T+365 US$79,450.51
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Paul Belsky: trading record in brief
All filings by Paul Belsky on record concern Heat Biologics, Inc. The record holds 4 filings, for trades running from 29 July 2013 to 16 May 2014.
Every open-market trade on record is a purchase: 3 purchases worth €7,492, and no sale. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2014 to date brings 2 purchases and no sales.
The latest filing, published on 16 May 2014, reports an open-market purchase of €3,665 in Heat Biologics, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Paul Belsky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,235 shares@ US$4.07Common StockSEC:0001553350-14-000561:0Canonical exit: 14 Aug 2014 (T+90)
- 1,265 shares@ US$4.15Common StockSEC:0001553350-14-000561:1Canonical exit: 14 Aug 2014 (T+90)
- 51 sharesCommon StockSEC:0001553350-13-000459:1Canonical exit: 27 Oct 2013 (T+90)
- 1,160 sharesCommon StockSEC:0001553350-13-000459:0
4 of 4 declarations